Cazzaniga, M.; Cardinali, M.; Di Pierro, F.; Zonzini, G.B.; Palazzi, C.M.; Gregoretti, A.; Zerbinati, N.; Guasti, L.; Matera, M.R.; Cavecchia, I.;
et al. The Role of Short-Chain Fatty Acids, Particularly Butyrate, in Oncological Immunotherapy with Checkpoint Inhibitors: The Effectiveness of Complementary Treatment with Clostridium butyricum 588. Microorganisms 2024, 12, 1235.
https://doi.org/10.3390/microorganisms12061235
AMA Style
Cazzaniga M, Cardinali M, Di Pierro F, Zonzini GB, Palazzi CM, Gregoretti A, Zerbinati N, Guasti L, Matera MR, Cavecchia I,
et al. The Role of Short-Chain Fatty Acids, Particularly Butyrate, in Oncological Immunotherapy with Checkpoint Inhibitors: The Effectiveness of Complementary Treatment with Clostridium butyricum 588. Microorganisms. 2024; 12(6):1235.
https://doi.org/10.3390/microorganisms12061235
Chicago/Turabian Style
Cazzaniga, Massimiliano, Marco Cardinali, Francesco Di Pierro, Giordano Bruno Zonzini, Chiara Maria Palazzi, Aurora Gregoretti, Nicola Zerbinati, Luigina Guasti, Maria Rosaria Matera, Ilaria Cavecchia,
and et al. 2024. "The Role of Short-Chain Fatty Acids, Particularly Butyrate, in Oncological Immunotherapy with Checkpoint Inhibitors: The Effectiveness of Complementary Treatment with Clostridium butyricum 588" Microorganisms 12, no. 6: 1235.
https://doi.org/10.3390/microorganisms12061235
APA Style
Cazzaniga, M., Cardinali, M., Di Pierro, F., Zonzini, G. B., Palazzi, C. M., Gregoretti, A., Zerbinati, N., Guasti, L., Matera, M. R., Cavecchia, I., & Bertuccioli, A.
(2024). The Role of Short-Chain Fatty Acids, Particularly Butyrate, in Oncological Immunotherapy with Checkpoint Inhibitors: The Effectiveness of Complementary Treatment with Clostridium butyricum 588. Microorganisms, 12(6), 1235.
https://doi.org/10.3390/microorganisms12061235
